DE602004015335D1 - Aminoalkyl-substituierte ester und amide von fumarsäure zur neutralisation von schlechtem geruch - Google Patents

Aminoalkyl-substituierte ester und amide von fumarsäure zur neutralisation von schlechtem geruch

Info

Publication number
DE602004015335D1
DE602004015335D1 DE602004015335T DE602004015335T DE602004015335D1 DE 602004015335 D1 DE602004015335 D1 DE 602004015335D1 DE 602004015335 T DE602004015335 T DE 602004015335T DE 602004015335 T DE602004015335 T DE 602004015335T DE 602004015335 D1 DE602004015335 D1 DE 602004015335D1
Authority
DE
Germany
Prior art keywords
amids
fumaric acid
alkyl substituted
amino alkyl
bad odor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004015335T
Other languages
German (de)
English (en)
Inventor
Felix Flachsmann
Markus Gautschi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Givaudan SA
Original Assignee
Givaudan SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Givaudan SA filed Critical Givaudan SA
Publication of DE602004015335D1 publication Critical patent/DE602004015335D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00—Disinfection, sterilisation or deodorisation of air
    • A61L9/01—Deodorant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00—Disinfection, sterilisation or deodorisation of air
    • A61L9/015—Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone
    • A61L9/04—Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone using substances evaporated in the air without heating
    • A61L9/044—Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone using substances evaporated in the air without heating with the help of an organic compound other than a macromolecular compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00—Disinfection, sterilisation or deodorisation of air
    • A61L9/14—Disinfection, sterilisation or deodorisation of air using sprayed or atomised substances including air-liquid contact processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C219/04—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C219/08—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the hydroxy groups esterified by a carboxylic acid having the esterifying carboxyl group bound to an acyclic carbon atom of an acyclic unsaturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/35—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/38—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a carbon atom of an acyclic unsaturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Disinfection, Sterilisation Or Deodorisation Of Air (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)
DE602004015335T 2003-09-02 2004-08-20 Aminoalkyl-substituierte ester und amide von fumarsäure zur neutralisation von schlechtem geruch Expired - Lifetime DE602004015335D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0320441.9A GB0320441D0 (en) 2003-09-02 2003-09-02 Organic compounds
PCT/CH2004/000525 WO2005021051A1 (en) 2003-09-02 2004-08-20 Aminoalkyl substituted esters and amides of fumaric acid for neutralising malodor

Publications (1)

Publication Number Publication Date
DE602004015335D1 true DE602004015335D1 (de) 2008-09-04

Family

ID=28686706

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004015335T Expired - Lifetime DE602004015335D1 (de) 2003-09-02 2004-08-20 Aminoalkyl-substituierte ester und amide von fumarsäure zur neutralisation von schlechtem geruch

Country Status (11)

Country Link
US (1) US7638118B2 (OSRAM)
EP (1) EP1735267B1 (OSRAM)
JP (1) JP2007503941A (OSRAM)
CN (1) CN100402095C (OSRAM)
AT (1) ATE402137T1 (OSRAM)
BR (1) BRPI0413878A (OSRAM)
DE (1) DE602004015335D1 (OSRAM)
ES (1) ES2309545T3 (OSRAM)
GB (1) GB0320441D0 (OSRAM)
MX (1) MXPA06002099A (OSRAM)
WO (1) WO2005021051A1 (OSRAM)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0501237D0 (en) * 2005-01-21 2005-03-02 Givaudan Sa Organic compounds
GB0526279D0 (en) * 2005-12-23 2006-02-01 Givaudan Sa Improvements in or related to organic compounds
RU2554347C2 (ru) 2008-08-19 2015-06-27 Ксенопорт, Инк. Пролекарства метилгидрофумарата, фармацевтические композиции с ними и способы применения
US8741275B2 (en) 2010-06-04 2014-06-03 Robetet, Inc. Malodor neutralizing compositions comprising undecylenic acid or citric acid
EP2668255B1 (en) 2011-01-27 2020-08-12 Robertet, Inc. Malodor neutralizing compositions comprising bornyl acetate or isobornyl acetate
US9126890B2 (en) * 2011-10-20 2015-09-08 International Flavors & Fragrances Inc. Low volatile reactive malodor counteractives and methods of use thereof
CN104169261A (zh) * 2012-02-07 2014-11-26 什诺波特有限公司 富马酸吗啉代烃基酯化合物、药物组合物和使用方法
US9114180B2 (en) 2012-03-30 2015-08-25 Robertet, Inc. Malodor neutralizing compositions containing acids and alicyclic ketones
EP2887934A1 (en) 2012-08-22 2015-07-01 XenoPort, Inc. Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effects
AU2013305684B2 (en) 2012-08-22 2016-11-24 Xenoport, Inc. Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
UA116648C2 (uk) 2013-03-14 2018-04-25 Алкермес Фарма Айерленд Лімітед Фумарати як проліки та їх застосування при лікуванні різних захворювань
US8669281B1 (en) 2013-03-14 2014-03-11 Alkermes Pharma Ireland Limited Prodrugs of fumarates and their use in treating various diseases
WO2014160633A1 (en) 2013-03-24 2014-10-02 Xenoport, Inc. Pharmaceutical compositions of dimethyl fumarate
US9302977B2 (en) 2013-06-07 2016-04-05 Xenoport, Inc. Method of making monomethyl fumarate
WO2014205392A1 (en) 2013-06-21 2014-12-24 Xenoport, Inc. Cocrystals of dimethyl fumarate
WO2015035184A1 (en) 2013-09-06 2015-03-12 Xenoport, Inc. Crystalline forms of (n,n-diethylcarbamoyl)methyl methyl (2e)but-2-ene-1,4-dioate, methods of synthesis and use
US9604922B2 (en) 2014-02-24 2017-03-28 Alkermes Pharma Ireland Limited Sulfonamide and sulfinamide prodrugs of fumarates and their use in treating various diseases
US9999672B2 (en) 2014-03-24 2018-06-19 Xenoport, Inc. Pharmaceutical compositions of fumaric acid esters
WO2016061393A1 (en) 2014-10-15 2016-04-21 Xenoport, Inc. Fumarate compounds, pharmaceutical compositions, and methods of use
US10226544B2 (en) 2015-06-05 2019-03-12 International Flavors & Fragrances Inc. Malodor counteracting compositions
WO2023069546A1 (en) * 2021-10-20 2023-04-27 International Flavors And Fragrances Inc. Novel 2,2'-(octylimino)bis[ethanol] compositions and uses thereof
CN115043741A (zh) * 2022-08-15 2022-09-13 江苏第二师范学院 一种全烷基取代的反丁烯二酸双氨基醇酯及其盐酸盐的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3077457A (en) 1960-04-15 1963-02-12 Fritzsche Brothers Inc Fumaric acid ester space deodorant and method of using same
GB969347A (en) 1961-08-28 1964-09-09 Fritzsche Brothers Inc Deodorant compositions
GB1206359A (en) 1968-08-02 1970-09-23 Nii Monomerov Dlya Sint Kauchu Method for production of aminoalkyl fumarates
DE1793142A1 (de) * 1968-08-08 1972-02-24 Nii Monomerow Dlja Sintetitsch Verfahren zur Herstellung von Fumarsaeureaminoalkylestern und neue Aminoalkylester dieser Saeure
US3580918A (en) * 1968-09-03 1971-05-25 Nii Monomerov Dlya Sint Method for the preparation of aminoalkyl fumarates
FR1588375A (OSRAM) 1968-10-15 1970-04-10
CH582003A5 (OSRAM) 1972-07-12 1976-11-30 Ciba Geigy Ag
JPS5441328A (en) * 1977-07-22 1979-04-02 Naarden International Nv Deodorant containing vinyether
JPH0657832B2 (ja) * 1985-06-11 1994-08-03 大同化学工業株式会社 金属圧延油組成物
US5601809A (en) 1986-09-26 1997-02-11 The Gillette Company Axillary malodor neutralization
WO1997008177A1 (en) 1995-08-31 1997-03-06 Nof Corporation Fumaric acid derivative and polymer thereof
US6610648B2 (en) 2000-12-22 2003-08-26 Givaudan Sa Malodor counteractant compositions
WO2003053487A1 (en) * 2001-12-20 2003-07-03 Basf Aktiengesellschaft Absorbent article

Also Published As

Publication number Publication date
BRPI0413878A (pt) 2006-10-24
EP1735267A1 (en) 2006-12-27
WO2005021051A1 (en) 2005-03-10
EP1735267B1 (en) 2008-07-23
GB0320441D0 (en) 2003-10-01
CN100402095C (zh) 2008-07-16
JP2007503941A (ja) 2007-03-01
CN1845758A (zh) 2006-10-11
US7638118B2 (en) 2009-12-29
MXPA06002099A (es) 2006-05-19
ATE402137T1 (de) 2008-08-15
ES2309545T3 (es) 2008-12-16
US20070009475A1 (en) 2007-01-11

Similar Documents

Publication Publication Date Title
DE602004015335D1 (de) Aminoalkyl-substituierte ester und amide von fumarsäure zur neutralisation von schlechtem geruch
EP1881823A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF OCULAR DISORDERS
EA201070247A1 (ru) Ингибиторы протеасом
EP1771582A4 (en) Modulators of odorant receptors
ATE557021T1 (de) Zur behandlung von erkrankungen des zns geeignete derivate des 4-piperazin-1-yl-4-benzoäbüthiophens
MX2007006316A (es) Composiciones de perfume.
EP1765391A4 (en) BACTERIAL COMPOSITIONS FOR THE TREATMENT OF CANCER
DE602006018583D1 (de) Verfahren und zusammensetzung zur behandlung von peripheren gefässkrankheiten
ATE545418T1 (de) Zusammensetzungen und kits zur behandlung von influenza
ATE544748T1 (de) Zusammensetzungen und verfahren für die behandlung von zellproliferationserkrankungen
EP1945754A4 (en) Compositions and methods for treating and diagnosing cancer
ATE434620T1 (de) Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen
ATE514656T1 (de) Miniatur-ozongenerator und verwendung davon zur reinigung von wasser
EP2219669A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF AUTOIMMUNE AND ALLERGIC DISEASES
DE602005022113D1 (de) Phenyl)methanon-derivate als glycin-transporter 1 (glyt-1) hemmer zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
ATE336175T1 (de) Verfahren zur geruchsneutralisation von sojaprotein-zusatzstoffe
DE602005015415D1 (de) N ausgewählter n-3-fettsäuren zur behandlung von erkrankungen des zentralen nervensystems
EA201170209A1 (ru) Производные пиперазина, применяемые в качестве модуляторов кальциевого канала ca2.2
EP1799270A4 (en) Compositions and methods for inhibiting expression of anti-apoptotic genes
DE602007009392D1 (de) Verfahren und system zur verbesserten hochintensitätsschallwellenanwendung
EP1948675A4 (en) METHODS AND COMPOSITIONS FOR TREATING MARFAN SYNDROME AND RELATED DISORDERS
DE602004019181D1 (de) Lichtquellenvorrichtung und Verfahren zur redundanten Schaltung dieser Lichtquelle
ZA200805473B (en) Inhibitors of fatty acid amide hydrolase
ATE504580T1 (de) Malonsäureamidderivate als inhibitoren von g- sekretase zur behandlung von alzheimer-krankheit
EP1885914A4 (en) NEUTRALIZATION AND RESERVATION OF REDUCTIONS PRODUCED BY EXPOSURE ELECTRODES

Legal Events

Date Code Title Description
8364 No opposition during term of opposition